Motahari Saeed 4
4 · Insys Therapeutics, Inc. · Filed Aug 10, 2017
Insider Transaction Report
Form 4
Motahari Saeed
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2017-08-10$8.92/sh+5,500$49,056→ 15,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.89 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.